Patient‐reported outcomes in Chinese patients with chronic myeloid leukemia receiving olverembatinib: Quality of life matters! 🔗 Access full article via ACS CancerCancer, Volume 131, Issue 3, 1 February 2025. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
